Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
MedPage Today on MSN
Gene therapy shows signs of delayed progression in fatal neurodegenerative disease
All participants had adverse events, but most were moderate in severity ...
Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand for AAV vectors, advancements in scalable production technologies like ...
A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated ...
A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are encapsulated into recombinant adeno-associated virus (rAAV) capsids as ...
Based on Ajinomoto Group’s collaborative development with Forge Biologics, now available worldwide Incheon, Korea — December 2025 — Ajinomoto CELLiST Korea, a subsidiary of the Ajinomoto Group ...
The RSUs will vest in four equal annual installments beginning on the first anniversary of the award's vesting commencement date, subject to such employee's continued service with the Company through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results